CF PharmTech (HKSE:02652) Tax Expense: HK$-17.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02652 CF PharmTech Inc HKSE:02652
15 GF Score
Price HK$17.35
! 5 Warning Signs
View Full Analysis

What is CF PharmTech Tax Expense?

CF PharmTech HKSE:02652 +0.81% 15 Tax Expense is HK$-17.6 Mil as of Dec. 2025. GuruFocus rates HKSE:02652 with a GF Score™ of 15/100. The stock has 5 warning signs investors should review.

CF PharmTech's tax expense for the six months ended in Dec. 2025 was HK$-17.6 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-17.6 Mil.


CF PharmTech  (HKSE:02652) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


CF PharmTech Tax Expense Related Terms


CF PharmTech Tax Expense Historical Data

* Premium members only.

The historical data trend for CF PharmTech's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CF PharmTech Tax Expense Chart

CF PharmTech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Tax Expense
-23.69 -10.15 -2.03 -17.56

CF PharmTech Semi-Annual Data
Dec22 Dec23 Dec24 Dec25
Tax Expense -23.69 -10.15 -2.03 -17.56
HKSE:02652
15GF Score
CF PharmTech Inc HKSE:02652
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CF PharmTech Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of HK$-17.6 Mil mean?
CF PharmTech (HKSE:02652) has a Tax Expense of HK$-17.6 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on CF PharmTech and its competitors.
Is CF PharmTech's Tax Expense too high?
CF PharmTech's current Tax Expense is HK$-17.6 Mil. Overall, CF PharmTech has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does CF PharmTech's Tax Expense compare to ZTS?
CF PharmTech's Tax Expense of HK$-17.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on CF PharmTech and its competitors. CF PharmTech's current Tax Expense is HK$-17.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CF PharmTech stock overvalued right now?
CF PharmTech (HKSE:02652) has a current Tax Expense of HK$-17.6 Mil. The current Tax Expense is HK$-17.6 Mil. CF PharmTech's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For CF PharmTech (HKSE:02652), the current Tax Expense is HK$-17.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CF PharmTech Business Description

Address No. 16, Hucundang Road, Xiangcheng Economic Development District, Jiangsu, Suzhou, CHN
CF PharmTech Inc is engaged in inhalation drug delivery technology. It is dedicated to building multidisciplinary bridges between complex formulations and unmet clinical needs. The Company is a specialist in the development of complex inhalation formulations with high barriers to entry, and a platform-based pharmaceutical company with integrated capabilities spanning device engineering, precision drug delivery, international regulatory filing, and commercialization. Leveraging its self-developed, globally integrated end-to-end capabilities, from exhalation-powered nasal spray delivery systems and liposomal inhalation technology to small interfering RNA (siRNA) nucleic acid delivery platforms. Its therapeutic areas encompass respiratory diseases and nasal diseases.
15GF Score

Get the complete analysis for HKSE:02652

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$17.35
Price